Apogee Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Apogee Therapeutics, Inc. (APGE) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $250.70 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-03-02
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $250.70M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $68.10M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $23.60M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $3.00M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $250.70M 10-K · filed 2026-03-02 |
| 2024-12-31 | $68.10M 10-K · filed 2026-03-02 |
| 2023-12-31 | $23.60M 10-K · filed 2025-03-03 |
| 2022-12-31 | $3.00M 10-K · filed 2024-03-05 |